Traditional vs Emerging Disease-
Modifying Therapies for Neuromuscular Disorders
This 5 part CME/CE accredited series reviews the pathophysiology of Neuromuscular Disorders, describes the limitations of current treatments, explores the data on newly approved and investigational therapies on the horizon, and details the importance of a multidisciplinary, team-based approach to care. In addition, patient vignettes will provide a voice to patients and caregivers, highlight their concerns and struggles, and frame faculty discussions and case scenarios. The Neuromuscular Disorders discussed include LEMS, Myasthenia Gravis, ALS, SMA, and Rett Syndrome.
This activity is jointly provided by Postgraduate Institute for Medicine (PIM) and PlatformQ Health Education, LLC.
Working in collaboration with the National Organization for Rare Disorders (NORD).